by Bruce Sylvester: Researchers have identified an across-the-board cardiovascular benefit for patients treated with a diabetes drug, liraglutide, with decreases reported in overall risk of heart attack, stroke,… read more.
by Gary Finnegan: Six medicines, including two combination therapies for chronic hepatitis C, have been recommended for approval at the May meeting of the European Medicines Agency’s Committee for… read more.
by Gary Finnegan: Cholesterol levels – the most common risk factor for heart attacks – have decreased in northern Sweden over the last 20 years. Since medication only… read more.
by Gary Finnegan: Hospital admissions for first-time stroke increased in young adults in Denmark during the past two decades, according to new research in Journal of the American Heart… read more.
by Bruce Sylvester: Psoriasis appears to be associated with type 2 diabetes, body mass index and obesity, researchers from a twin study reported on April 27, 2016 in… read more.
by Bruce Sylvester: During three years following bariatric surgery, a majority of patients achieved improvement in pain, physical function, and walk time, researchers reported on April 5 2016… read more.
by Bruce Sylvester: A very low-calorie diet appears to enable adults to reverse type 2 diabetes, and, notably, remain diabetes-free if weight-loss is maintained. Researchers reported these findings… read more.
Best practice immunosuppression – no more Mr Nice Guy. Nicholas Torpey, Addenbrooke’s Hospital, Cambridge. Overview by Maria Dalby The updated recommendations from the National Institute for Health… read more.
Best practice immunosuppression – no more Mr Nice Guy. Nicholas Torpey, Addenbrooke’s Hospital, Cambridge. Overview by Maria Dalby The updated recommendations from the National Institute for Health… read more.
by Gary Finnegan: Infants that gain weight in their first year of life are more likely to develop type 1 diabetes, according to a study of children born… read more.
by Bruce Sylvester: Women who have problems sleeping are at an increased risks of developing type 2 diabetes, researchers reported on January 28, 2016 in Diabetologia.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
